Abstract
BACKGROUND--Bronchiectasis and pulmonary infections are common in patients with hypogammaglobulinaemia. Despite intravenous gammaglobulin treatment and appropriate antibiotics, a subgroup of patients remains with persistent localised pulmonary infection in segments where bronchiectasis had developed before appropriate treatment. As such localised pulmonary suppuration (segmental or lobar) may serve as a focus for progression of bronchiectasis, surgical resection of the involved segments may be considered. The outcome of pulmonary resection in four such patients is reported. RESULTS--Surgery was well tolerated except for one postoperative empyema. Information on follow up is available from 3.5 to 5 years. All patients experienced considerable reduction of symptoms including cough, sputum production, antibiotic use, and hospital admissions. CONCLUSIONS--Surgical resection of localised bronchiectatic segments should be considered in patients with hypogammaglobulinaemia with persistent localised suppuration and symptoms refractory to medical treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Annest L. S., Kratz J. M., Crawford F. A., Jr Current results of treatment of bronchiectasis. J Thorac Cardiovasc Surg. 1982 Apr;83(4):546–550. [PubMed] [Google Scholar]
- Barker A. F., Bardana E. J., Jr Bronchiectasis: update of an orphan disease. Am Rev Respir Dis. 1988 Apr;137(4):969–978. doi: 10.1164/ajrccm/137.4.969. [DOI] [PubMed] [Google Scholar]
- Campbell D. N., Lilly J. R. The changing spectrum of pulmonary operations in infants and children. J Thorac Cardiovasc Surg. 1982 May;83(5):680–685. [PubMed] [Google Scholar]
- Dukes R. J., Rosenow E. C., 3rd, Hermans P. E. Pulmonary manifestations of hypogammaglobulinaemia. Thorax. 1978 Oct;33(5):603–607. doi: 10.1136/thx.33.5.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dwyer J. M. Thirty years of supplying the missing link. History of gamma globulin therapy for immunodeficient states. Am J Med. 1984 Mar 30;76(3A):46–52. doi: 10.1016/0002-9343(84)90319-x. [DOI] [PubMed] [Google Scholar]
- Long A. A., Denburg J. A., Dent P. B. Hypogammaglobulinemia: therapeutic rationale. CMAJ. 1987 Nov 1;137(9):793–797. [PMC free article] [PubMed] [Google Scholar]
- Marcy T. W., Reynolds H. Y. Pulmonary consequences of congenital and acquired primary immunodeficiency states. Clin Chest Med. 1989 Dec;10(4):503–519. [PubMed] [Google Scholar]
- Roifman C. M., Lederman H. M., Lavi S., Stein L. D., Levison H., Gelfand E. W. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med. 1985 Aug;79(2):171–174. doi: 10.1016/0002-9343(85)90006-3. [DOI] [PubMed] [Google Scholar]
- Roifman C. M., Levison H., Gelfand E. W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1987 May 9;1(8541):1075–1077. doi: 10.1016/s0140-6736(87)90494-6. [DOI] [PubMed] [Google Scholar]